Leonid Barski1, Roman Nevzorov2, Alan Jotkowitz2, Elena Rabaev2, Miri Zektser2, Lior Zeller2, Elena Shleyfer2, Ilana Harman-Boehm3, Yaniv Almog4. 1. Department of Internal Medicine F, Soroka University Medical Center, Beer-Sheva, Israel. Electronic address: lbarski@bgu.ac.il. 2. Department of Internal Medicine F, Soroka University Medical Center, Beer-Sheva, Israel. 3. Diabetes Unit, Soroka University Medical Center, Beer-Sheva, Israel. 4. Medical Intensive Care Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Abstract
BACKGROUND: Diabetic ketoacidosis (DKA) occurs most often in patients with type 1 diabetes, however patients with type 2 diabetes are also susceptible to DKA under stressful conditions. The aims of our study were to evaluate and compare the clinical and biochemical characteristics and outcomes of type 1 versus type 2 diabetes mellitus (DM) patients with DKA. METHODS: A retrospective cohort study of adult patients hospitalized with DKA between January 1, 2003, and January 1, 2010. The clinical and biochemical characteristics of DKA patients with type-1 DM were compared with those of patients with type-2 DM. The primary outcome was in-hospital all-cause mortality. RESULTS: The study cohort included 201 consecutive patients for whom the admission diagnosis was DKA: 166 patients (82.6%) with type-1 DM and 35 patients (17.4%) with type-2 DM. The patients with DKA and type-2 DM were significantly older than patients with type-1 DM (64.3 versus 37.3, P < 0.001). Significantly more patients with severe forms of DKA were seen in the group with type-2 DM (25.7% versus 9.0%, P = 0.018). The total in-hospital mortality rate of patients with DKA was 4.5%. The primary outcome was significantly worse in the group of patients with type-2 DM. CONCLUSIONS: DKA in patients with type-2 DM is a more severe disease with worse outcomes compared with type-1 DM. Advanced age, mechanical ventilation and bed-ridden state were independent predictors of 30-day mortality.
BACKGROUND:Diabetic ketoacidosis (DKA) occurs most often in patients with type 1 diabetes, however patients with type 2 diabetes are also susceptible to DKA under stressful conditions. The aims of our study were to evaluate and compare the clinical and biochemical characteristics and outcomes of type 1 versus type 2 diabetes mellitus (DM) patients with DKA. METHODS: A retrospective cohort study of adult patients hospitalized with DKA between January 1, 2003, and January 1, 2010. The clinical and biochemical characteristics of DKA patients with type-1 DM were compared with those of patients with type-2 DM. The primary outcome was in-hospital all-cause mortality. RESULTS: The study cohort included 201 consecutive patients for whom the admission diagnosis was DKA: 166 patients (82.6%) with type-1 DM and 35 patients (17.4%) with type-2 DM. The patients with DKA and type-2 DM were significantly older than patients with type-1 DM (64.3 versus 37.3, P < 0.001). Significantly more patients with severe forms of DKA were seen in the group with type-2 DM (25.7% versus 9.0%, P = 0.018). The total in-hospital mortality rate of patients with DKA was 4.5%. The primary outcome was significantly worse in the group of patients with type-2 DM. CONCLUSIONS: DKA in patients with type-2 DM is a more severe disease with worse outcomes compared with type-1 DM. Advanced age, mechanical ventilation and bed-ridden state were independent predictors of 30-day mortality.
Authors: Rachel A Wolf; J Sonya Haw; Sudeshna Paul; Melissa Spezia Faulkner; EunSeok Cha; M K Findley; Farah Khan; Sara Markley Webster; Anastasia-Stefania Alexopoulos; Komal Mehta; David A Alfa; Mohammed K Ali Journal: Diabetes Res Clin Pract Date: 2019-09-24 Impact factor: 5.602
Authors: Alexander J Eckert; Julia K Mader; Marcus Altmeier; Steffen Mühldorfer; Anton Gillessen; Dhayana Dallmeier; Viral N Shah; Christoph Heyer; Bettina Hartmann; Reinhard W Holl Journal: J Diabetes Complications Date: 2020-06-27 Impact factor: 2.852
Authors: Nikifor K Konstantinov; Mark Rohrscheib; Emmanuel I Agaba; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas Journal: World J Diabetes Date: 2015-07-25
Authors: René Rodríguez-Gutiérrez; Carlos R Cámara-Lemarroy; Dania L Quintanilla-Flores; Emanuel I González-Moreno; Juan Manuel González-Chávez; Fernando Javier Lavalle-González; Jose Gerardo González-González; A Enrique Caballero Journal: Biomed Res Int Date: 2015-06-21 Impact factor: 3.411